Impact of Utilizing a Composite versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire.

Chipps, Bradley E; Zeiger, Robert S; Beuther, David A; Wise, Robert A; McCann, William; Reibman, Joan; George, Maureen; Gilbert, Ileen; Eudicone, James M; Coyne, Karin S; Harding, Gale; Murphy, Kevin R

Chipps, Bradley E; Zeiger, Robert S; Beuther, David A; Wise, Robert A; McCann, William; Reibman, Joan; George, Maureen; Gilbert, Ileen; Eudicone, James M; Coyne, Karin S; Harding, Gale; Murphy, Kevin R.

Afiliação

Chipps BE; Capital Allergy & Respiratory Disease Center, Sacramento, CA, USA.
Zeiger RS; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Beuther DA; Department of Medicine, National Jewish Health, Denver, CO, USA.
Wise RA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
McCann W; Allergy Partners, Asheville, NC, USA.
Reibman J; Department of Medicine, New York University School of Medicine, New York, NY, USA.
George M; Columbia University School of Nursing, New York, NY, USA.
Gilbert I; BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
Eudicone JM; BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
Coyne KS; Evidera, Bethesda, MD, USA.
Harding G; Evidera, Bethesda, MD, USA.
Murphy KR; Boys Town National Research Hospital, Boys Town, NE, USA.

J Asthma Allergy ; 17: 751-756, 2024.

Article em En | MEDLINE | ID: mdl-39131600

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Asthma Allergy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google